Gsk (GSK) Cash from Investing Activities (QoQ) (2009 - 2026)

Gsk (GSK) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -59.26%
Mar 31, 2025 -280.77%
Mar 31, 2024 88.90%
Mar 31, 2023 89.78%
Mar 31, 2022 -1,435.00%
Mar 31, 2021 98.49%
Dec 31, 2020 -225.13%
Mar 31, 2020 98.72%
Dec 31, 2019 -906.01%
Mar 31, 2019 -531.66%
Mar 31, 2018 39.83%
Mar 31, 2017 78.47%
Mar 31, 2016 -109.50%
Mar 31, 2015 1,505.17%
Dec 31, 2014 -111.95%
Mar 31, 2014 -775.31%
Dec 31, 2013 92.26%
Mar 31, 2013 -227.84%
Mar 31, 2012 184.19%
Mar 31, 2011 145.31%